EBOS Group Correlations
| EBOSY Stock | USD 35.03 0.00 0.00% |
The current 90-days correlation between EBOS Group Limited and Stratec SE is 0.02 (i.e., Significant diversification). The correlation of EBOS Group is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
EBOS Group Correlation With Market
Pay attention - limited upside
The correlation between EBOS Group Limited and DJI is -0.79 (i.e., Pay attention - limited upside) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding EBOS Group Limited and DJI in the same portfolio, assuming nothing else is changed.
EBOS |
The ability to find closely correlated positions to EBOS Group could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace EBOS Group when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back EBOS Group - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling EBOS Group Limited to buy it.
Moving together with EBOS Pink Sheet
Moving against EBOS Pink Sheet
| 0.81 | AA | Alcoa Corp | PairCorr |
| 0.77 | AS | Amer Sports | PairCorr |
| 0.73 | HSIC | Henry Schein | PairCorr |
| 0.73 | SVNLY | Svenska Handelsbanken | PairCorr |
| 0.68 | MLI | Mueller Industries | PairCorr |
| 0.66 | PRLB | Proto Labs Trending | PairCorr |
| 0.65 | GALNF | Galenica AG | PairCorr |
| 0.57 | AZNCF | AstraZeneca PLC Earnings Call Tomorrow | PairCorr |
| 0.55 | BASFY | BASF SE ADR | PairCorr |
| 0.55 | NPTVF | Nippon Television | PairCorr |
| 0.48 | SHPMF | Shanghai Pharmaceuticals | PairCorr |
| 0.48 | MLCG | ML Capital Group | PairCorr |
| 0.47 | FULC | Fulcrum Therapeutics | PairCorr |
| 0.45 | TAYO | Taylor Consulting | PairCorr |
| 0.45 | BCPC | Balchem Earnings Call This Week | PairCorr |
| 0.45 | AUST | Austin Gold Corp | PairCorr |
| 0.42 | AAWH | Ascend Wellness Holdings | PairCorr |
| 0.33 | BOCOF | Bougainville Copper | PairCorr |
| 0.85 | UBS | UBS Group AG | PairCorr |
| 0.81 | PACS | PACS Group | PairCorr |
| 0.77 | EGBN | Eagle Bancorp | PairCorr |
| 0.76 | SMDZF | Strategic Metals | PairCorr |
| 0.72 | AMAT | Applied Materials Earnings Call This Week | PairCorr |
| 0.72 | EBC | Eastern Bankshares | PairCorr |
| 0.69 | BECEF | BCE Inc | PairCorr |
| 0.68 | 225313AN5 | ACAFP 2811 11 | PairCorr |
| 0.64 | FTCI | FTC Solar | PairCorr |
Related Correlations Analysis
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between EBOS Pink Sheet performing well and EBOS Group Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze EBOS Group's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| STSEY | 0.06 | 0.02 | 0.00 | 6.15 | 0.00 | 0.00 | 2.00 | |||
| SZUKF | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| ARSUF | 0.42 | 0.18 | 0.00 | (0.62) | 0.00 | 0.00 | 14.09 | |||
| IUSDF | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| TTALF | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| MEDGF | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| PIAHY | 0.59 | 0.25 | 0.00 | 0.55 | 0.00 | 0.00 | 18.60 | |||
| ZRSEF | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| EKTAF | 1.74 | 0.33 | 0.06 | 0.72 | 1.83 | 5.19 | 39.33 | |||
| DRWKF | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in EBOS Group without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Backtesting Now
Portfolio BacktestingAvoid under-diversification and over-optimization by backtesting your portfolios |
| All Next | Launch Module |
EBOS Group Corporate Management
| Janelle Cain | General Counsel | Profile | |
| Brett Barons | Executive General Manager - Pharmacy | Profile | |
| Andrea Bell | Chief Officer | Profile | |
| John Cullity | Chief Officer | Profile | |
| Jacinta McCarthy | Group HR | Profile | |
| Julie Dillon | Chief Care | Profile |